Monish Aron, MD, MCh

Professor of Clinical Urology

S.H. Ho Foundation Chair in Urologic Oncologic Surgery

Vice Chair of Clinical Operations and Director, Center for Outpatient Cancer Ablation

Vice Chairman, Department of Urology

Image of Monish Aron, MD, MCh
Is this your profile? Click to edit

Overview

Dr. Monish Aron is an expert in robotic and laparoscopic surgery for malignant and benign conditions of the prostate, kidney, bladder, adrenal gland, and ureter. He trained in urology at some of the premier institutions in India, Australia, and the United States. Dr. Aron completed his fellowship training in advanced robotics and laparoscopy at the Cleveland Clinic, and was recruited to USC in 2009.

He has received numerous acclaimed awards including the GB Ong Medal from the Royal College of Surgeons of Edinburgh, as well as several awards for his scientific presentations and surgical videos at the American Urological Association Congress. Dr. Aron has published extensively (>200 publications) and serves as reviewer for 8 leading urologic journals, including editorial board appointments for 3 journals.

Dr. Aron has played a pioneering role in the development and refinement of robotic prostate and kidney surgery, single incision laparoscopic surgery, and robotic surgery for bladder cancer. Dr. Aron has been invited to speak at and demonstrate minimally invasive surgical techniques at numerous national and international institutions.

Publications

  • Upstaging to pT3a disease in patients undergoing robotic partial nephrectomy for cT1 kidney cancer: Outcomes and predictors from a multi-institutional dataset. Urol Oncol. 2020 04; 38(4):286-292.. View in PubMed
  • Chemoradiation for Management of Locally Recurrent or Residual Bladder Cancer: A Case Series and Review of the Literature. Clin Genitourin Cancer. 2020 08; 18(4):e473-e477.. View in PubMed
  • A Young Female With Refractory Hypertension. Urology. 2020 Jan; 135:e1.. View in PubMed
  • Robotic partial nephrectomy versus radical nephrectomy in elderly patients with large renal masses. Minerva Urol Nefrol. 2020 Feb; 72(1):99-108.. View in PubMed
  • Salvage Radical Prostatectomy for Recurrent Prostate Cancer: Morbidity and Functional Outcomes from a Large Multicenter Series of Open versus Robotic Approaches. J Urol. 2019 10; 202(4):725-731.. View in PubMed
  • Radical cystectomy pentafecta: a proposal for standardisation of outcomes reporting following robot-assisted radical cystectomy. BJU Int. 2020 01; 125(1):64-72.. View in PubMed
  • Factors influencing ICU admission and associated outcome in patients undergoing radical cystectomy with enhanced recovery pathway. Urol Oncol. 2019 09; 37(9):572.e13-572.e19.. View in PubMed
  • Surgical approach as a determinant factor of clinical outcome following radical cystectomy: Does Enhanced Recovery After Surgery (ERAS) level the playing field? Urol Oncol. 2019 10; 37(10):765-773. Ch . View in PubMed
  • Long-term oncologic outcomes of robot-assisted radical cystectomy (RARC) with totally intracorporeal urinary diversion (ICUD): a multi-center study. World J Urol. 2020 Apr; 38(4):837-843.. View in PubMed
  • Editorial Comment. J Urol. 2019 07; 202(1):67.. View in PubMed